Trade GlaxoSmithKline plc (Extended hours) - GSK CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.32 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 33.27 |
| Open | 33.27 |
| 1-Year Change | -16.43% |
| Day's Range | 33.22 - 33.65 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jan 17, 2025 | 33.28 | -0.23 | -0.69% | 33.51 | 33.67 | 32.97 |
| Jan 16, 2025 | 33.27 | 0.50 | 1.53% | 32.77 | 33.45 | 32.67 |
| Jan 15, 2025 | 32.67 | 0.62 | 1.93% | 32.05 | 32.86 | 31.95 |
| Jan 14, 2025 | 31.95 | -0.42 | -1.30% | 32.37 | 32.41 | 31.66 |
| Jan 13, 2025 | 32.65 | -0.10 | -0.31% | 32.75 | 32.81 | 32.49 |
| Jan 10, 2025 | 32.95 | -0.49 | -1.47% | 33.44 | 33.49 | 32.95 |
| Jan 8, 2025 | 33.55 | -0.45 | -1.32% | 34.00 | 34.15 | 33.27 |
| Jan 7, 2025 | 33.95 | 0.10 | 0.30% | 33.85 | 34.40 | 33.75 |
| Jan 6, 2025 | 33.85 | 0.19 | 0.56% | 33.66 | 34.06 | 33.37 |
| Jan 3, 2025 | 33.28 | -0.45 | -1.33% | 33.73 | 34.07 | 33.09 |
| Jan 2, 2025 | 33.73 | -0.11 | -0.33% | 33.84 | 34.13 | 33.69 |
| Jan 1, 2025 | 33.75 | 0.00 | 0.00% | 33.75 | 33.75 | 33.75 |
| Dec 31, 2024 | 33.75 | 0.20 | 0.60% | 33.55 | 34.01 | 33.37 |
| Dec 30, 2024 | 33.55 | -0.40 | -1.18% | 33.95 | 34.19 | 33.50 |
| Dec 27, 2024 | 33.85 | -0.12 | -0.35% | 33.97 | 34.12 | 33.61 |
| Dec 26, 2024 | 34.07 | 0.02 | 0.06% | 34.05 | 34.12 | 33.83 |
| Dec 24, 2024 | 33.60 | -0.35 | -1.03% | 33.95 | 34.15 | 33.53 |
| Dec 23, 2024 | 33.75 | 0.25 | 0.75% | 33.50 | 34.05 | 33.49 |
| Dec 20, 2024 | 33.45 | 0.12 | 0.36% | 33.33 | 33.81 | 32.87 |
| Dec 19, 2024 | 33.33 | -0.31 | -0.92% | 33.64 | 33.96 | 33.16 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
GlaxoSmithKline Company profile
About GlaxoSmithKline plc (ADR)
GlaxoSmithKline PLC is a global healthcare company. The Company researches and develops a range of products in three primary areas: Pharmaceuticals, Vaccines and Consumer Healthcare. Its product formulations include tablets, creams/ointments, inhalers, injections, liquids and sterile products. Its Pharmaceuticals business has a portfolio of established medicines in respiratory, human immunodeficiency virus (HIV), immuno-inflammation and oncology. Its Vaccines business has a portfolio of vaccines to help protect people from a range of diseases throughout their lives. Its vaccines tackle diseases, including pneumococcal disease, meningitis, hepatitis, rotavirus, whooping cough and influenza. Its Consumer Healthcare business combines science and consumer insights to create everyday healthcare brands that consumers trust, and experts recommend for oral health, pain relief, cold, flu and allergy, digestive health and vitamins, minerals and supplements.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, GlaxoSmithKline plc (ADR) revenues increased less than 1% to £34.11B. Net income decreased 24% to £4.39B. Revenues reflect Pharmaceuticals segment increase of 4% to £17.73B, US segment increase of 4% to £15.09B, also reflect Consumer Healthcare segment decrease of 4% to £9.61B, Vaccines segment decrease of 3% to £6.78B, Unallocated segment decrease from £28M to £0K.
Equity composition
Ordinary Shs. 25p Par, 05/11, 10B auth., 5,657,488,184 issd., less 494,074,284 Treas. shs. @ Cost. Insiders own 0.02%. PO: NA. 11/91, 9/89, & 2/86,2-for-1 stock splits. 2/00, Company formed through merger with SmithKline Beecham plc @ 1 ADR-for-1.138 ADS of GSK and Glaxo Wellcome plc @ 1.
| Industry: | Pharmaceuticals (NEC) |
980 Great West Road
BRENTFORD
MIDDLESEX TW8 9GS
GB
News
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
12:40, 31 December 2024
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com